Vimarsana
Biggest News Aggregation in the World

Page 13 - Sysmex Inostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sysmex Inostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sysmex Inostics Today - Breaking & Trending Today

Liquid Biopsy Market worth $5.8 billion by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Liquid Biopsy Market worth $5.8 billion by 2026 - Exclusive Report by MarketsandMarkets™

/PRNewswire/ -- According to the new market research report "Liquid Biopsy Market by Product (Assay Kits, Instruments, Service), Circulating Biomarkers (CTC,...

Liquid Biopsy Market worth $5.8 billion by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Liquid Biopsy Market worth $5.8 billion by 2026 - Exclusive Report by MarketsandMarkets™

/PRNewswire/ -- According to the new market research report "Liquid Biopsy Market by Product (Assay Kits, Instruments, Service), Circulating Biomarkers (CTC,...

New Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics - Vimarsana News

New Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics

/PRNewswire/ -- Sysmex Inostics has developed a new CLIA-validated liquid biopsy test for the detection of Minimal Residual Disease (MRD) in Acute Myeloid...

Global Whole Genome and Exome Sequencing Market Report 2021: Rapid Genome Sequencing Could Revolutionize Health Care - Vimarsana News

Global Whole Genome and Exome Sequencing Market Report 2021: Rapid Genome Sequencing Could Revolutionize Health Care

/PRNewswire/ -- The "Whole Genome And Exome Sequencing Markets" report has been added to ResearchAndMarkets.com's offering. Will all newborns receive Whole...

Global Molecular Diagnostics for Cancer Markets Report 2021-2025: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs; COVID-19 Causes Resources Shift - Vimarsana News

Global Molecular Diagnostics for Cancer Markets Report 2021-2025: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs; COVID-19 Causes Resources Shift

7 Molecular Diagnostics Recent Developments 7.1 Recent Developments - Importance and How to Use This Section 7.1.1 Importance of These Developments 7.1.2 How to Use This Section 7.2 Nucleix to Invest in Early-Stage Lung Cancer Dx 7.3 Invitae to Acquire Genosity for $200M 7.4 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test 7.5 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience 7.6 Natera Revenues Grow 35 Percent 7.7 AnchorDx Closes $40M Financing Round 7.8 Exact Sciences Strategy for End-to-End Cancer Testing 7.9 Genomics England: Whole Genome Sequenci...